Eribulin Mesylate in Treating Patients With Advanced or Recurrent Cervical Cancer

NCT01676818 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Cervical Cancer
Stage IIIA Cervical Cancer
Stage IIIB Cervical Cancer
Stage IVA Cervical Cancer
Stage IVB Cervical Cancer

Interventions

DRUG: eribulin mesylate

Sponsor

University of Southern California

Collaborators

[object Object]